Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 469-487
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.469
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.469
Table 2 Characteristics of 26 randomized controlled trials, including comparison group (number), administration time (before, during, after, and before/after endoscopic retrograde cholangiopancreatography)
Ref. | Comparison (n) | Administration time (after, before, and during) | n | Intervention |
Andrade et al[24], 2015 | Glycerin (84) | Before ERCP | 166 | 82 |
Bhatia et al[6], 2011 | Glyceryl trinitrate (127) | Before ERCP | 254 | 127 |
Cheon et al[10], 2007 | Placebo SN (102) | Before and after ERCP | 207 | 105 |
Döbrönte et al[7], 2014 | Placebo SN (318) | After ERCP | 665 | 347 |
Elmunzer et al[25], 2012 | Placebo SN (307) | After ERCP | 602 | 295 |
Hauser et al[11], 2016 | Ceftazidime (143) | Before ERCP | 272 | 129 |
Ishiwatari et al[12]., 2016 | Placebo SN (214) | Before and after ERCP | 430 | 216 |
Kato et al[31], 2017 | Saline solution (85) | Before ERCP | 170 | 85 |
Kato et al[13]., 2019 | None (152) | Before ERCP | 303 | 151 |
Khoshbaten et al[14], 2008 | Placebo SN (50) | Before ERCP | 100 | 50 |
Leerhøy et al[15], 2016 | None (394) | After ERCP | 772 | 378 |
Levenick et al[26], 2016 | Placebo SN (226) | During ERCP | 449 | 223 |
Li et al[27], 2019 | Glycerin (50) | Before ERCP | 100 | 50 |
Lua et al[16], 2015 | None (75) | After ERCP | 144 | 69 |
Mansour et al[32], 2016 | Placebo SN (162) | Before ERCP | 324 | 162 |
Masjedizadeh et al[26], 2017 | Placebo lactated Ringer’s solution (124) | Before ERCP | 186 | 62 |
Montaño et al[23], 2007 | Glycerin (75) | Before ERCP | 150 | 75 |
Hosseini et al[28], 2016 | Saline solution (205) | Before ERCP | 406 | 201 |
Murray et al[17], 2003 | Placebo SN (110) | After ERCP | 220 | 110 |
Otsuka et al[18], 2012 | Saline solution (53) | Before ERCP | 104 | 51 |
Park et al[21], 2014 | Saline solution (170) | After ERCP | 343 | 173 |
Patai et al[29], 2015 | Placebo SN (269) | Before ERCP | 539 | 270 |
Quadros et al[33], 2016 | Saline solution (253) | After ERCP | 477 | 224 |
Senol et al[19], 2009 | Placebo SN (40) | After ERCP | 80 | 40 |
Sotoudehmanesh et al[30], 2007 | Placebo SN (245) | After ERCP | 490 | 245 |
Uçar et al[20], 2016 | None (50) | Before ERCP | 150 | 100 |
Total | - | - | 8103 | 4020 |
- Citation: Román Serrano JP, Jukemura J, Romanini SG, Guamán Aguilar PF, Castro JSL, Torres IT, Sanchez Pulla JA, Micelli Neto O, Taglieri E, Ardengh JC. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis. World J Gastrointest Endosc 2020; 12(11): 469-487
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/469.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.469